💨 Abstract

India's drug regulator aims to ease export clearances for unapproved drugs, simplify manufacturing licensing, and develop a digital drug regulatory system to address its workforce burden. The regulator also plans to remove licensing requirements for research, simplify manufacturing for testing drugs, and develop guidelines for cell and gene therapy and biosimilars.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖